A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with 68Ga 44Sc 177Lu and 161Tb

摘要

The production of novel radionuclides is the first step towards the development of new effective radiopharmaceuticals, and the quality thereof directly affects the preclinical and clinical phases. In this review, novel radiometal production for medical applications is briefly elucidated. The production status of the imaging nuclide Sc and the therapeutic β -emitter nuclide Tb are compared to their more established counterparts, Ga and Lu according to their targetry, irradiation process, radiochemistry, and quality control aspects. The detailed discussion of these significant issues will help towards the future introduction of these promising radionuclides into drug manufacture for clinical application under Good Manufacturing Practice (GMP).